Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review

Chavan, 2014, International variations in bladder cancer incidence and mortality, Eur Urol, 66, 59, 10.1016/j.eururo.2013.10.001 Sievert, 2009, Economic aspects of bladder cancer: what are the benefits and costs?, World J Urol, 27, 295, 10.1007/s00345-009-0395-z Babjuk, 2017, EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016, Eur Urol, 71, 447, 10.1016/j.eururo.2016.05.041 Brausi, 2002, Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies, Eur Urol, 41, 523, 10.1016/S0302-2838(02)00068-4 Herr, 1999, The value of a second transurethral resection in evaluating patients with bladder tumors, J Urol, 162, 74, 10.1097/00005392-199907000-00018 Gendy, 2016, Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series, BJU Int, 117, 54, 10.1111/bju.13265 Ali, 2010, Evaluation of second-look transurethral resection in restaging of patients with nonmuscle-invasive bladder cancer, J Endourol, 24, 2047, 10.1089/end.2010.0319 Bishr, 2014, Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer, Can Urol Assoc J, 8, E306, 10.5489/cuaj.1514 Neuzillet, 2014, Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology, Urol Oncol Semin Orig Investig, 32, 1135, 10.1016/j.urolonc.2014.04.005 Divrik, 2010, Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial, Eur Urol, 58, 185, 10.1016/j.eururo.2010.03.007 Grimm, 2003, Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study, J Urol, 170, 433, 10.1097/01.ju.0000070437.14275.e0 Angulo, 2014, Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guerin, Actas Urol Esp, 38, 164, 10.1016/j.acuro.2014.01.001 Gontero, 2016, The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guerin, BJU Int, 118, 44, 10.1111/bju.13354 Novara, 2010, Does routine second transurethral resection affect the long-term outcome of patients with T1 bladder cancer? Why a flawed randomized controlled trial cannot address the issue, Eur Urol, 58, 193, 10.1016/j.eururo.2010.04.012 Deeks, 2003, Evaluating non-randomised intervention studies, Health Technol Assess, 7, 1, 10.3310/hta7270 Reeves, 2011 Schwaibold, 2006, The value of a second transurethral resection for T1 bladder cancer, BJU Int, 97, 1199, 10.1111/j.1464-410X.2006.06144.x Herr, 2005, Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy, J Urol, 174, 2134, 10.1097/01.ju.0000181799.81119.fc Fritsche, 2010, Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort, Eur Urol, 57, 300, 10.1016/j.eururo.2009.09.024 Herr, 2006, A re-staging transurethral resection predicts early progression of superficial bladder cancer, BJU Int, 97, 1194, 10.1111/j.1464-410X.2006.06145.x Sfakianos, 2014, The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guerin, J Urol, 191, 341, 10.1016/j.juro.2013.08.022 Witjes, 2012, Prognosis of T1G3 bladder cancer: how well can we predict progression?, Eur Urol, 62, 126, 10.1016/j.eururo.2011.11.001 Naselli A, Hurle R, Paparella S, et al. Role of restaging transurethral resection for T1 non-muscle invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Focus. In press. doi:10.1016/j.euf.2016.12.011. Kim, 2012, Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor, J Endourol, 26, 1059, 10.1089/end.2011.0576 Andius, 2007, Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion, Urology, 70, 758, 10.1016/j.urology.2007.06.638 Orsola, 2010, Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacilli Calmette-Guérin therapy and the decision for a repeat TUR, BJU Int, 105, 202, 10.1111/j.1464-410X.2009.08694.x Mariappan, 2012, BJU Int, 109, 1666, 10.1111/j.1464-410X.2011.10571.x Gordon PC, Thomas F, Noon AP, Rosario DJ, Catto JW. Long-term outcomes from re-resection for high-risk non-muscle invasive bladder cancer: A potential to rationalize use. Eur Urol Focus. In press. doi:10.1016/j.euf.2017.10.004. Fujikawa, 2012, An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer, Indian J Urol, 28, 267, 10.4103/0970-1591.102697 Han, 2008, Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: the referral cancer center experience and review of the literature, J Endourol, 22, 2699, 10.1089/end.2008.0281 Engelhardt, 2001, Ranking of the 2nd-look transurethral electroresection of the superficial carcinoma of the bladder, Aktuelle Urol, 32, 173, 10.1055/s-2001-15848 Audenet, 2017, Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?, Urol Oncol, 35, 10.1016/j.urolonc.2017.06.042 Hashine, 2016, Results of second transurethral resection for high-grade T1 bladder cancer, Urol Ann, 8, 10, 10.4103/0974-7796.163798 Kamiya, 2017, Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study, Int J Clin Oncol, 22, 353, 10.1007/s10147-016-1048-z Iida, 2016, Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer, BMC Urol, 16, 8, 10.1186/s12894-016-0126-x Sanseverino, 2016, Prognostic impact of ReTURB in high grade T1 primary bladder cancer, Arch Ital Urol Androl, 88, 81, 10.4081/aiua.2016.2.81 Un, 2016, Is a second look necessary in multiple and/or large Ta tumors?, Arch Ital Urol Androl, 88, 86, 10.4081/aiua.2016.2.86 Cao, 2015, Repeated transurethral resection for non-muscle invasive bladder cancer, Int J Clin Exp Med, 8, 1416 Turk, 2016, Factors that predict residual tumors in re-TUR patients, Afr J Urol, 22, 67, 10.1016/j.afju.2015.07.004 Gill, 2014, Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer, Urol Ann, 6, 305, 10.4103/0974-7796.140990 Takaoka, 2013, Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era, Jpn J Clin Oncol, 43, 404, 10.1093/jjco/hyt016 Geavlete, 2012, Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors—results of a prospective, randomized comparison to the standard approach, Urology, 79, 846, 10.1016/j.urology.2011.08.081 Huang, 2012, Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissue, Urol Int, 89, 319, 10.1159/000341103 Richterstetter, 2012, The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer, BJU Int, 110, E76, 10.1111/j.1464-410X.2011.10904.x Vasdev, 2012, The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer, Ecancermedicalscience, 6, 269 Katumalla, 2011, Second transurethral resection in T1G3 bladder tumors—selectively avoidable?, Indian J Urol, 27, 176, 10.4103/0970-1591.82833 Parkin, 2011, G3T1 bladder cancer: is early re-resection necessary?, Br J Med Surg Urol, 4, 13, 10.1016/j.bjmsu.2010.04.004 Yucel, 2010, Is repeat transurethral resection effective and necessary in patients with T1 bladder carcinoma?, Urol Int, 85, 276, 10.1159/000316073 Dwivedi, 2009, in superficial bladder cancer: its importance and its correlation with the tumor ploidy, Urol Oncol, 27, 514, 10.1016/j.urolonc.2008.04.015 Zurkirchen, 2004, Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists, Urol Int, 72, 99, 10.1159/000075961 Schips, 2002, Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?, Urology, 59, 220, 10.1016/S0090-4295(01)01522-9